Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07424625 · ClinicalTrials.gov registry record · Phase 4

A Study of Tris-Hydroxymethyl Aminomethane (THAM) Versus Sodium Bicarbonate in Cardiac Surgical Patients

A Phase 4 study, sponsored by Mayo Clinic.

Not yet
Registry status
Phase 4
Development phase
250
Enrollment target

NCT07424625: Clinical Trial Phase 4 study, sponsored by Mayo Clinic.

NCT07424625 is a Phase 4 study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 250 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07424625, a Phase 4 study, has not yet begun recruiting, sponsored by Mayo Clinic.

NOT YET RECRUITING
Registry status
Phase 4
Development phase
250 participants
Enrollment target

Study Summary

The purpose of this research is to determine if two commonly used medications to treat metabolic acidosis in the setting of cardiac surgery, sodium bicarbonate and THAM, are equivalent.

Primary Outcome

pH will be measured via arterial blood gas test

Interventions

  • DRUG Sodium bicarbonate
  • DRUG Tris-hydroxymethyl Aminomethane

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2026-07
Est. Completion 2027-08
Phase Phase 4
Mayo Clinic

2,844 total trials

What is known before NCT07424625 opens enrollment

NCT07424625 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (52% lower).

The record links to 0 conditions, and to 2 interventions - of which Sodium bicarbonate is the first listed.

NCT07424625 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07424625 about?

NCT07424625 is a clinical study titled "A Study of Tris-Hydroxymethyl Aminomethane (THAM) Versus Sodium Bicarbonate in Cardiac Surgical Patients". The purpose of this research is to determine if two commonly used medications to treat metabolic acidosis in the setting of cardiac surgery, sodium bicarbonate and THAM, are equivalent.

What is the current status of trial NCT07424625?

This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2026-07. Estimated completion is 2027-08.

What interventions are being tested in trial NCT07424625?

The interventions under investigation include: Sodium bicarbonate (DRUG), Tris-hydroxymethyl Aminomethane (DRUG).

Who is sponsoring clinical trial NCT07424625?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07424625's enrollment target sits among peer trials

250 342nd of 2000 higher than 1,648 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07424625, the US trial registry maintained by the National Library of Medicine. NCT07424625 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.